Para a preparação EUDR, o código SH/NC 300290 está classificado como fora do âmbito.
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; toxins, cultures of micro-organisms and similar products (excl. yeasts and vaccines) O motor de âmbito indexado devolve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Porque é que esta página de referência dá essa resposta.
- Descrição do código
- Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; toxins, cultures of micro-organisms and similar products (excl. yeasts and vaccines)
- Base no anexo I
- Sem entrada direta no anexo I
- Base da fonte
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Linhas ascendentes, descendentes e próximas.
A vista de biblioteca destina-se à navegação de referência. Use o verificador quando quiser executar outro código como ação.
30produtos farmacêuticosout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout30029010human blood(2002-2500);human blood(1988-2001)out30029030animal blood prepared for therapeutic, prophylactic or diagnostic uses(2002-2500);animal blood prepared for therapeutic, prophylactic or diagnostic uses(1988-2001)out30029050cultures of micro-organisms (excl. yeasts)(2002-2021);cultures of microorganisms (excl. yeasts)(1988-2001)out30029090toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)(2022-2022);toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)(2017-2021);toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)(2012-2016);toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)(2002-2011);toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of microorganisms)(1988-2001)out300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout300211malaria diagnostic test kitsout300212antisera and other blood fractionsout300213immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleout300214immunological products, mixed, not put up in measured doses or in forms or packings for retail saleout300215immunological products, put up in measured doses or in forms or packings for retail saleout
O que isto significa para a preparação.
Esta linha não desencadeia diretamente a recolha de provas no resultado de âmbito atual.
Regulation (EU) 2023/1115 Annex I — relevant productsobtido em 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115obtido em 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)obtido em 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)obtido em 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8obtido em 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingobtido em 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersobtido em 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)obtido em 2026-08-08